Integral Health Asset Management »

GSK shares owned by Integral Health Asset Management

Quarter-by-quarter ownership of GSK (GSK) shares owned by Integral Health Asset Management from 13F filings

Historical chart of Integral Health Asset Management investment in GSK

Tip: Access up to 7 years of quarterly data

All positions including GSK held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in GSK by Integral Health Asset Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $13M 350k 35.64

More positions owned by Integral Health Asset Management

Insmed Com Par $.01 (INSM)
Cytokinetics Com New Call Option (CYTK)
Tenet Healthcare Corp Com New (THC)
Mineralys Therapeutics (MLYS)
Vera Therapeutics Cl A (VERA)
Uniqure Nv SHS (QURE)
Brightspring Health Svcs (BTSG)
Boston Scientific Corporation (BSX)
Newamsterdam Pharma Company Ordinary Shares Put Option (NAMS)
Regeneron Pharmaceuticals (REGN)
Alignment Healthcare (ALHC)
Alnylam Pharmaceuticals (ALNY)
Novartis Sponsored Adr (NVS)
Encompass Health Corp (EHC)
Edgewise Therapeutics (EWTX)

View all positions for Integral Health Asset Management

Top funds holding GSK

Dodge & Cox
FMR
Fisher Investments
PRIMECAP Management Company
JTC Employer Solutions Trustee
Royal Bank of Canada
Goldman Sachs Group
Holocene Advisors
State Street Corporation
UBS Group
Mondrian Investment Partners
Hotchkis and Wiley Capital Management
Equity Investment Corp Acquisition
Manufacturers Life Insurance Company
Federated Investors

View all funds holding GSK